AICDA and diabetes mellitus: These results, which support a role for AID expression in regulating B cell class switch recombination and subsequent T cell negative selection, are in agreement with previous clinical studies which linked AID mutations with peripheral organ autoimmunity including diabetes in patients with hyper-IgM syndrome (95).